These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9373451)

  • 21. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA; Greenstadt MA; Wheeler WS; Kletzky OA; Nicoloff JT
    J Clin Endocrinol Metab; 1980 Oct; 51(4):771-5. PubMed ID: 6774994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyrotropin-releasing hormone degradation in patients with insulin dependent diabetes mellitus. Effects of metabolic control.
    Duntas L; Keck FS; Wolf C; Hauner H; Pfeiffer EF
    Thyroidology; 1991 May; 3(2):51-7. PubMed ID: 1726900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuro-endocrine correlations of hypothalamic-pituitary-thyroid axis in healthy humans.
    Mazzoccoli G; Carughi S; Sperandeo M; Pazienza V; Giuliani F; Tarquini R
    J Biol Regul Homeost Agents; 2011; 25(2):249-57. PubMed ID: 21880214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are the thyroid and adrenal system alterations linked in depression?
    Mokrani MC; Duval F; Erb A; Gonzalez Lopera F; Danila V
    Psychoneuroendocrinology; 2020 Dec; 122():104831. PubMed ID: 33068950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of seasonal variation in abnormal TSH secretion in patients with seasonal affective disorder.
    Coiro V; Volpi R; Marchesi C; De Ferri A; d'Amato L; Caffarri G; Davolio M; Rossi E; Caffarra P; Chiodera P
    Biol Psychiatry; 1994 Jan; 35(1):36-41. PubMed ID: 8167202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian variation of thyrotropin in childhood.
    Rose SR; Nisula BC
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1086-90. PubMed ID: 2498382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lack of nocturnal serum thyrotropin surge in patients with nontoxic nodular goiter may predict the subsequent occurrence of hyperthyroidism.
    Bartalena L; Martino E; Velluzzi F; Piga M; Petrini L; Loviselli A; Grasso L; Pinchera A
    J Clin Endocrinol Metab; 1991 Sep; 73(3):604-8. PubMed ID: 1874936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hypothalamic-pituitary-thyroid axis in type 1 diabetes: influence of diabetic metabolic control.
    MacFarlane IA; Sheppard MC; Black EG; Gilbey S; Wright AD
    Acta Endocrinol (Copenh); 1984 May; 106(1):92-6. PubMed ID: 6428119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamics of serum thyrotropin and thyroid hormone changes in fasting.
    Spencer CA; Lum SM; Wilber JF; Kaptein EM; Nicoloff JT
    J Clin Endocrinol Metab; 1983 May; 56(5):883-8. PubMed ID: 6403568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of hypothalamic-pituitary-adrenal axis in amenorrhoeic women with insulin-dependent diabetes.
    la Marca A; Morgante G; De Leo V
    Hum Reprod; 1999 Feb; 14(2):298-302. PubMed ID: 10099967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
    Van den Berghe G; de Zegher F; Vlasselaers D; Schetz M; Verwaest C; Ferdinande P; Lauwers P
    Crit Care Med; 1996 Apr; 24(4):590-5. PubMed ID: 8612408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for normal feedback inhibition of triiodothyronine on the thyrotropin (TSH) response to thyrotropin-releasing hormone (TRH) in abstinent male alcoholics.
    Garbutt JC; McDavid J; Mason GA; Quade D; Loosen PT
    Alcohol Clin Exp Res; 1992 Oct; 16(5):881-3. PubMed ID: 1443425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The response of thyrotropin and triiodothyronine to various doses of thyrotropin releasing hormone in normal man.
    Weeke J
    Eur J Clin Invest; 1975 Nov; 5(6):447-53. PubMed ID: 811471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients.
    Yonemura K; Nakajima T; Suzuki T; Ando S; Genma R; Nakamura H; Hishida A
    Nephrol Dial Transplant; 2000 May; 15(5):668-72. PubMed ID: 10809808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TSH and PRL responses to domperidone and TRH in men with insulin-dependent diabetes mellitus of different duration.
    Coiro V; Butturini U; Gnudi A; Volpi R; d'Amato L; Speroni G; Capretti L; Roti E; Chiodera P
    Horm Res; 1987; 25(4):206-14. PubMed ID: 3108134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
    Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED
    J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
    Ekman AC; Vakkuri O; Ekman M; Leppäluoto J; Ruokonen A; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of cholinergic blockade on nocturnal thyrotropin and growth hormone (GH) secretion in type I diabetes mellitus: further evidence supporting somatostatin's involvement in GH suppression.
    Goñi MJ; Monreal M; Goñi F; Sopena M; Gil MJ; Moncada E; Salvador J
    Metabolism; 1997 Nov; 46(11):1305-11. PubMed ID: 9361690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.